A Responsible Framework for Applying Artificial Intelligence on Medical Images and Signals at the Point of Care: The PACS-AI Platform.

Journal: The Canadian journal of cardiology
Published Date:

Abstract

The potential of artificial intelligence (AI) in medicine lies in its ability to enhance clinicians' capacity to analyse medical images, thereby improving diagnostic precision and accuracy and thus enhancing current tests. However, the integration of AI within health care is fraught with difficulties. Heterogeneity among health care system applications, reliance on proprietary closed-source software, and rising cybersecurity threats pose significant challenges. Moreover, before their deployment in clinical settings, AI models must demonstrate their effectiveness across a wide range of scenarios and must be validated by prospective studies, but doing so requires testing in an environment mirroring the clinical workflow, which is difficult to achieve without dedicated software. Finally, the use of AI techniques in health care raises significant legal and ethical issues, such as the protection of patient privacy, the prevention of bias, and the monitoring of the device's safety and effectiveness for regulatory compliance. This review describes challenges to AI integration in health care and provides guidelines on how to move forward. We describe an open-source solution that we developed that integrates AI models into the Picture Archives Communication System (PACS), called PACS-AI. This approach aims to increase the evaluation of AI models by facilitating their integration and validation with existing medical imaging databases. PACS-AI may overcome many current barriers to AI deployment and offer a pathway toward responsible, fair, and effective deployment of AI models in health care. In addition, we propose a list of criteria and guidelines that AI researchers should adopt when publishing a medical AI model to enhance standardisation and reproducibility.

Authors

  • Pascal Theriault-Lauzier
    Division of Cardiovascular Medicine, Stanford School of Medicine, Palo Alto, California, USA.
  • Denis Cobin
    Heartwise (heartwise.ai), Montréal Heart Institute, Montréal, Québec, Canada.
  • Olivier Tastet
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada.
  • Elodie Labrecque Langlais
    Division of Cardiology, Department of Medicine, Montreal Heart Institute, University of Montreal, QC, Canada.
  • Bahareh Taji
    Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Guson Kang
    VA Palo Alto Health Care System, Cardiovascular Medicine, CA (G.K.).
  • Aun-Yeong Chong
    Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Derek So
    Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • An Tang
    Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada.
  • Judy Wawira Gichoya
    Department of Interventional Radiology, Oregon Health & Science University, Portland, Oregon; Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia.
  • Sarath Chandar
    University of Montreal, Montreal QC H3T 1J4, Canada apsarathchandar@gmail.com.
  • Pierre-Luc Deziel
    Faculty of Law, Université Laval, Quebec, QC, Canada.
  • Julie G Hussin
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada; Faculté de Médecine, Université de Montréal, Montreal, Quebec, Canada; Mila - Québec AI Institute, Montreal, Quebec, Canada.
  • Samuel Kadoury
    École Polytechnique de Montréal, Montreal, Canada. samuel.kadoury@polymtl.ca.
  • Robert Avram
    Division of Cardiology, Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, QC H1T 1C8, Canada. Electronic address: robert.avram.md@gmail.com.